Syros Pharmaceuticals (SYRS) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-4.01
-2.73
-1.45
-0.17

Details

Expected EPS
-1.13
Actual EPS
-1.3
Surprise EPS
-0.17
Surprise Percent
+15.04%

Description

Syros Pharmaceuticals (SYRS) has reported earnings of -1.3 per share for Q2 2023.

0 Comments

Share your thoughts